NCT03617783View on ClinicalTrials.gov

Prebiotic Treatment in People With Schizophrenia - Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 18, 2019

Primary Completion Date

April 5, 2022

Study Completion Date

April 5, 2022

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Prebiotin

Prebiotin (12g/day), an oligofructose-enriched inulin (OEI)

DRUG

Placebo

placebo-OEI

Trial Locations (1)

21228

Maryland Psychiatric Research Center (MPRC) Treatment Research Program (TRP), Catonsville

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT03617783 - Prebiotic Treatment in People With Schizophrenia - Pilot Study | Biotech Hunter | Biotech Hunter